StonvexLoading…
StonvexStonvexStonvexCore line items from FSLR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.04B | $5.22B | $3.54B | $1.94B |
Operating Income | $345.30M | $1.60B | $1.05B | $582.85M |
Net Income | $346.62M | $1.53B | $1.01B | $551.40M |
EPS (Diluted) | $3.22 | $14.21 | $9.37 | $5.13 |
Total Assets | $13.35B | $13.32B | $13.46B | $12.86B |
Total Liabilities | $3.47B | $3.78B | $4.44B | $4.31B |
Cash & Equivalents | $2.36B | $2.80B | $1.99B | $1.12B |
Free Cash Flow OCF − CapEx | $-333.39M | $1.19B | $117.06M | $-952.50M |
Shares Outstanding | 107.45M | 107.31M | 107.31M | 107.25M |